Reuters logo
BRIEF-Incyte and AstraZeneca to enter clinical trial collaboration in early lung cancer
October 31, 2017 / 7:11 AM / 23 days ago

BRIEF-Incyte and AstraZeneca to enter clinical trial collaboration in early lung cancer

Oct 31 (Reuters) - Incyte Corp

* Incyte and AstraZeneca to enter clinical trial collaboration in early lung cancer

* Incyte - ‍phase 3 trial evaluating Imfinzi and epacadostat in patients with unresectable non-small cell lung cancer is expected to begin in first-half 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below